Chemotherapy in early breast cancer: when, how and which one?
about
Nanodrug Formed by Coassembly of Dual Anticancer Drugs to Inhibit Cancer Cell Drug Resistance.Effects of Jia-Wei-Xiao-Yao-San on the Peripheral and Lymphatic Pharmacokinetics of Paclitaxel in Rats.Topotecan-induced ABCG2 expression in MCF-7 cells is associated with decreased CD24 and EpCAM expression and a loss of tumorigenicity.Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.
P2860
Chemotherapy in early breast cancer: when, how and which one?
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Chemotherapy in early breast cancer: when, how and which one?
@ast
Chemotherapy in early breast cancer: when, how and which one?
@en
Chemotherapy in early breast cancer: when, how and which one?
@nl
type
label
Chemotherapy in early breast cancer: when, how and which one?
@ast
Chemotherapy in early breast cancer: when, how and which one?
@en
Chemotherapy in early breast cancer: when, how and which one?
@nl
prefLabel
Chemotherapy in early breast cancer: when, how and which one?
@ast
Chemotherapy in early breast cancer: when, how and which one?
@en
Chemotherapy in early breast cancer: when, how and which one?
@nl
P2860
P356
P1433
P1476
Chemotherapy in early breast cancer: when, how and which one?
@en
P2093
Marcus Schmidt
P2860
P304
P356
10.1159/000363755
P577
2014-07-01T00:00:00Z